vildagliptin
Showing 26 - 50 of 121
Type 2 Diabetes Trial in Lund (Vildagliptin, Dapagliflozin)
Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Metformin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +3 more
-
Buenos Aires, Santa Fe, Argentina
- +186 more
Dec 17, 2020
Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- Placebo
-
Pell City, Alabama
- +175 more
Dec 11, 2020
Type 2 Diabetes Trial in Worldwide (Placebo of vildagliptin, vildagliptin, Metformin)
Completed
- Type 2 Diabetes Mellitus
- Placebo of vildagliptin
- +2 more
-
Caba, Buenos Aires, Argentina
- +227 more
Sep 1, 2020
Type 2 Diabetes Trial in Mexico (Vildagliptin, Insulin, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Vildagliptin
- +2 more
-
Mexico, Distrito Federal, Mexico
- +12 more
Jun 3, 2019
TYpe 2 Diabetes Trial in India (Metformin, Vildagliptin)
Completed
- TYpe 2 Diabetes Mellitus
- Metformin
- Vildagliptin
-
Bangalore, Karnataka, India
- +5 more
Apr 1, 2019
Type 2 Diabetes Trial in Korea, Republic of (vildagliptin, Pioglitazone)
Diabetes, Type 2, Ischemic Heart Disease Trial in Chiang Mai (vildagliptin, Dapagliflozin)
Completed
- Diabetes Mellitus, Type 2
- Ischemic Heart Disease
- vildagliptin
- Dapagliflozin
-
Chiang Mai, ThailandFaculty of Medicine, Chiang Mai University
Jul 17, 2018
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
Jul 31, 2017
Diabetes, Type 2 Trial in Investigative Sites (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Investigative Sites, Germany(unnamed)
Jul 31, 2017
1- Microvascular Function, 2-oxidative Stress, 3-inflammation Trial in Rio de Janeiro (Vildagliptin)
Completed
- 1- Microvascular Function
- +2 more
- Vildagliptin
-
Rio de Janeiro, BrazilLaboratory for Clinical and Experimental Research on Vascular Bi
May 30, 2017
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
May 16, 2017
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
May 15, 2017
Diabetes, Type 2 Trial in East Hanover, Investigative Centers (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New Jersey
- +1 more
May 15, 2017
Insulin Resistance, Microvascular Disease Trial in Exeter (Vildagliptin, Placebo)
Completed
- Insulin Resistance
- Microvascular Disease
- Vildagliptin
- Placebo
-
Exeter, Devon, United KingdomDiabetes and Vascular Research Department
Apr 24, 2017
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
Feb 28, 2017
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
Feb 28, 2017
Diabetes, Type 2 Trial in East Hanover (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
East Hanover, New JerseyNovartis Pharmaceuticals
Feb 28, 2017
Diabetes, Type 2 Trial in Basel (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
Basel, SwitzerlandNovartis Pharmaceuticals
Feb 28, 2017
Type 2 Diabetes Trial in Cairo (vildagliptin)
Completed
- Type 2 Diabetes Mellitus
- vildagliptin
-
Cairo, EgyptInvestigative site
Feb 23, 2017
Diabetes, Type 2 Trial in Bochum (vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
-
Bochum, GermanyNovartis Investigative Site
Feb 23, 2017
Diabetes, Type 2 Trial in Munich (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Munich, GermanyMunich, 81377, Germany
Feb 20, 2017
Diabetes, Type 2 Trial in East Hanover, Investigative Centers (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
-
East Hanover, New Jersey
- +1 more
Feb 20, 2017